Purine import into malaria parasites as a target for antimalarial drug development

I. J. Frame, Roman Deniskin, Avish Arora, Myles Akabas

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Infection with Plasmodium species parasites causes malaria. Plasmodium parasites are purine auxotrophs. In all life cycle stages, they require purines for RNA and DNA synthesis and other cellular metabolic processes. Purines are imported from the host erythrocyte by equilibrative nucleoside transporters (ENTs). They are processed via purine salvage pathway enzymes to form the required purine nucleotides. The Plasmodium falciparum genome encodes four putative ENTs (PfENT1-4). Genetic, biochemical, and physiologic evidence suggest that PfENT1 is the primary purine transporter supplying the purine salvage pathway. Protein mass spectrometry shows that PfENT1 is expressed in all parasite stages. PfENT1 knockout parasites are not viable in culture at purine concentrations found in human blood (<10 μM). Thus, PfENT1 is a potential target for novel antimalarial drugs, but no PfENT1 inhibitors have been identified to test the hypothesis. Identifying inhibitors of PfENT1 is an essential step to validate PfENT1 as a potential antimalarial drug target.

Original languageEnglish (US)
Pages (from-to)19-28
Number of pages10
JournalAnnals of the New York Academy of Sciences
Volume1342
Issue number1
DOIs
StatePublished - Apr 1 2015

Fingerprint

Antimalarials
Malaria
Parasites
Nucleoside Transport Proteins
Salvaging
Purines
Purine Nucleotides
Plasmodium
Plasmodium falciparum
Life Cycle Stages
Mass spectrometry
Life cycle
Molecular Biology
Mass Spectrometry
Blood
Genes
Erythrocytes
purine
Import
Parasite

Keywords

  • Drug development
  • Malaria
  • Nucleoside transporter
  • Purines

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Purine import into malaria parasites as a target for antimalarial drug development. / Frame, I. J.; Deniskin, Roman; Arora, Avish; Akabas, Myles.

In: Annals of the New York Academy of Sciences, Vol. 1342, No. 1, 01.04.2015, p. 19-28.

Research output: Contribution to journalArticle

@article{e11e8e8fa4ff4103a49a036ec5c4206f,
title = "Purine import into malaria parasites as a target for antimalarial drug development",
abstract = "Infection with Plasmodium species parasites causes malaria. Plasmodium parasites are purine auxotrophs. In all life cycle stages, they require purines for RNA and DNA synthesis and other cellular metabolic processes. Purines are imported from the host erythrocyte by equilibrative nucleoside transporters (ENTs). They are processed via purine salvage pathway enzymes to form the required purine nucleotides. The Plasmodium falciparum genome encodes four putative ENTs (PfENT1-4). Genetic, biochemical, and physiologic evidence suggest that PfENT1 is the primary purine transporter supplying the purine salvage pathway. Protein mass spectrometry shows that PfENT1 is expressed in all parasite stages. PfENT1 knockout parasites are not viable in culture at purine concentrations found in human blood (<10 μM). Thus, PfENT1 is a potential target for novel antimalarial drugs, but no PfENT1 inhibitors have been identified to test the hypothesis. Identifying inhibitors of PfENT1 is an essential step to validate PfENT1 as a potential antimalarial drug target.",
keywords = "Drug development, Malaria, Nucleoside transporter, Purines",
author = "Frame, {I. J.} and Roman Deniskin and Avish Arora and Myles Akabas",
year = "2015",
month = "4",
day = "1",
doi = "10.1111/nyas.12568",
language = "English (US)",
volume = "1342",
pages = "19--28",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Purine import into malaria parasites as a target for antimalarial drug development

AU - Frame, I. J.

AU - Deniskin, Roman

AU - Arora, Avish

AU - Akabas, Myles

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Infection with Plasmodium species parasites causes malaria. Plasmodium parasites are purine auxotrophs. In all life cycle stages, they require purines for RNA and DNA synthesis and other cellular metabolic processes. Purines are imported from the host erythrocyte by equilibrative nucleoside transporters (ENTs). They are processed via purine salvage pathway enzymes to form the required purine nucleotides. The Plasmodium falciparum genome encodes four putative ENTs (PfENT1-4). Genetic, biochemical, and physiologic evidence suggest that PfENT1 is the primary purine transporter supplying the purine salvage pathway. Protein mass spectrometry shows that PfENT1 is expressed in all parasite stages. PfENT1 knockout parasites are not viable in culture at purine concentrations found in human blood (<10 μM). Thus, PfENT1 is a potential target for novel antimalarial drugs, but no PfENT1 inhibitors have been identified to test the hypothesis. Identifying inhibitors of PfENT1 is an essential step to validate PfENT1 as a potential antimalarial drug target.

AB - Infection with Plasmodium species parasites causes malaria. Plasmodium parasites are purine auxotrophs. In all life cycle stages, they require purines for RNA and DNA synthesis and other cellular metabolic processes. Purines are imported from the host erythrocyte by equilibrative nucleoside transporters (ENTs). They are processed via purine salvage pathway enzymes to form the required purine nucleotides. The Plasmodium falciparum genome encodes four putative ENTs (PfENT1-4). Genetic, biochemical, and physiologic evidence suggest that PfENT1 is the primary purine transporter supplying the purine salvage pathway. Protein mass spectrometry shows that PfENT1 is expressed in all parasite stages. PfENT1 knockout parasites are not viable in culture at purine concentrations found in human blood (<10 μM). Thus, PfENT1 is a potential target for novel antimalarial drugs, but no PfENT1 inhibitors have been identified to test the hypothesis. Identifying inhibitors of PfENT1 is an essential step to validate PfENT1 as a potential antimalarial drug target.

KW - Drug development

KW - Malaria

KW - Nucleoside transporter

KW - Purines

UR - http://www.scopus.com/inward/record.url?scp=84927792241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927792241&partnerID=8YFLogxK

U2 - 10.1111/nyas.12568

DO - 10.1111/nyas.12568

M3 - Article

VL - 1342

SP - 19

EP - 28

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -